Naive human T cells develop into Th1 effectors after stimulation with mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 6826-6832

  Russo, Donna M ^a,c   Kozlova, Natalia ^a   Lakey, David L ^b,d   Kernodle, Douglas ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS;

ANTIGENS, BACTERIAL; CELL LINE; HUMANS; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; TH1 CELLS;

EID: 0034444309     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.6826-6832.2000     Document Type: Article

References (41)

1. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamumura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482-3489.
2. Barnes, P. F., R. L. Modlin, and J. J. Ellner. 1994. T-cell responses and cytokines, p. 417-435. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
3. Boesen, H., B. N. Jensen, T. Wilcke, and P. Anderson. 1995. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect. Immun. 63:1491-1497.
4. Boom, W. H., R. S. Wallis, and K. A. Chervenak. 1991 Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect. Immun. 59:2737-2743.
5. Boom, W. H., K. A. Chervenal, M. A. Mincek, and J. J. Ellner. 1992. Role of the mononuclear phagocyte as an antigen-presenting cell for human γδ T cells activated by live Mycobacterium tuberculosis. Infect. Immun. 60:3480-3488.
6. Carlucci, S., A. Beshin, L. Tuosto, F. Ameglio, F. Fandolfo, C. Cocito, F. Fiorucci, C. Saltini, and E. Piccolella. 1993. Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis. Infect. Immun. 61:439-447.
7. Centers for Disease Control and Prevention. 1999. Tuberculosis elimination revisited: obstacles, opportunities and renewed commitment - Advisory Council for the Elimination of Tuberculosis (ACET). Morb. Mortal. Wkly. Rep. 48:1-13.
8. Connell, N., E. Medina-Acosta, W. R. McMaster, B. Bloom, and D. Russell. 1993. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. USA 90:11473-11477.
9. Content, A., A. De La Cuvellerie, L. De Wit, V. Vincent-Levy-Frebault, J. Ooms, and J. DeBruyn. 1991. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85C of M. tuberculosis. Infect. Immun. 59:3205-3212.
10. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-12017.
11. Garcia, V. E., K. Uyemura, P. A. Sieling, M. T. Ochoa, C. T. Morita, H. Okamura, M. Kurimoto, T. H. Rea, and R. L. Modlin. 1999. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J. Immunol. 162:6114-6121.
12. Gong, J., S. Stenger, J. A. Zack, B. E. Jones, G. C. Bristol, R. L. Modlin, P. J. Morrissey, and P. F. Barnes. 1998. Isolation of Mycobacterium reactive CD1-restricted T cells from patients with human immunodeficiency virus infection. J. Clin. Investig. 101:383-389.
13. Haanen, J. B., R. de Waal Malefit, P. C. Res, E. M. Kraakman, T. H. Ottenhoff, R. R. de Vries, and H. Spits. 1991. Selection of a human T helper type 1 subset by mycobacteria. J. Exp. Med. 174:583-592.
14. Handman, E., L. L. Button, and R. W. McMaster. 1990. Leishmania major: production of recombinant gp63, its antigenicity and immunogenicity in mice. Exp. Parasitol. 70:427-432.
15. Havlir, D. V., R. S. Wallis, W. H. Boom, T. M. Daniel, K. Chervenak, and J. J. Ellner. 1991. Human immune response to Mycobacterium tuberculosis antigens. Infect. Immun. 59:665-670.
16. Havlir, D. V., J. J. Ellner, K. A. Chervenak, and W. H. Boom. 1991. Selective expansion of human γδ T cells by monocytes infected by live Mycobacterium tuberculosis. J. Clin. Investig. 87:729-733.
17. Horwitz, M. A., B. W. E. Lee, B. J. Dillionn, and G. Harth. 1995. Protection immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92: 1530-1534.
18. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. Dewitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J. P. Van Vooren, M. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med 2:893-898.
19. Jardim, A., J. Alexander, H. S. Teh, D. Ou, and R. W. Olafson. 1990. Immunoprotective Leishmania major synthetic T cell epitopes. J. Exp. Med. 172:645.
20. Johnson, B. J., and D. N. McMurray. 1994. Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes. Infect. Immun. 62:1444-1450.
21. Kaufmann, S. H. E. 1988. CD8+ T lymphocytes in intracellular microbial infections. Immunol. Today 9:168-174.
22. Kumararatne, D. S., A. S. Pithie, P. Drysdale, J. S. Gaston, R. Kiessling, P. B. Iyes, C. J. Ellis, J. Innes, and R. Wise. 1990. Specific lysis of mycobacterial antigen bearing macrophages by class II MHC restricted polyclonal T cell lines in healthy donors or patients with tuberculosis. Clin. Exp. Immunol. 80:314-323.
23. Lakey, D. L., R. K. R. Voladri, K. M. Edwards, C. Hager, B. Samten, R. S. Wallis, P. F. Barnes, and Douglas S. Kernddle. 2000. Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. 68:233-238.
24. Launois, P., R. DeLeys, M. Niang, A. Srowart, M. Andrien, P. Dierckx, J.-L. Cartel, J.-L. Sarthou, J.-P. Van Vooren, and K. Huygen. 1994. T cell mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62:3679-3687.
25. Lopez, J., H. Reins, R. Etges, L. Button, W. R. McMaster, P. Overathe, and J. Klein. 1991. Genetic control of the immune response in mice to Leishmania mexicana surface protease. J. Immunol. 146:1328.
26. McDyer, J. F., M. N. Hackley, T. E. Walsh, J. L. Cook, and R. A. Seder. 1997. Patients with multidrug-resistent tuberculosis with low CD4+ T cell counts have impaired Th1 responses. J. Immunol. 158:492-500.
27. Mehra, V., J. Gong, D. Iyer, Y. G. Lin, C. T. Boylen, B. R. Bloom, and P. F. Barnes. 1996. Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J. Infect. Dis:431-434.
28. Murray, C. J., and J. A. Salomon. 1998. Modeling the impact of global tuberculosis control strategies. Proc. Natl. Acad. Sci. USA 95:13881-13886.
29. Orme, I. M., P. Anderson, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481-1497.
30. Russell, D. G., and J. Alexander. 1988. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140:1274-1280.
31. Russo, D. M., J. M. Burns, Jr., E. Carvalho, A. Barral, R. McMaster, L. Button, and S. G. Reed. 1990. Human T cell responses to native and recombinant gp63. J. Immunol. 47:3575.
32. Russo, D. M., P. Chakrabarti, and J. M. Burns, Jr. 1998. Naive human T cells develop into Th1 or Th2 effectors and exhibit cytotoxicity early after stimulation with Leishmania infected macrophages. J. Infect. Dis. 177:1345.
33. Sanchez, F. O., J. I. Rodriguez, G. Agudelo, and L. F. Garcia. 1994. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 62:5673-5678.
34. Stenger, S. R., J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J.-P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, and R. L. Modlin. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Scî ence 276:1684-1687.
35. Sugawara, I., H. Yamada, H. Kaneko, S. Mizuno, K. Takeda, and S. Akira. 1999. Role of interleukin 18 (IL-18) in mycobacterial infection in IL-18 gene-disrupted mice. Infect. Immun. 67:2585-2589.
36. Thompson-Snipes, L., E. Skamene, and D. Radzioch. 1998. Acquired resiŝ tance but not innate resistance to Mycobacterium bovis bacillus Calmette-Guérin is compromised by interleukin-12 ablation. Infect. Immun. 66:5268-5274.
37. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secreted product of Mycobacterium tuberculosis. Microbiol. Rev. 56:648-661.
38. Yang, D. M., N. Fairweather, L. L. Button, W. R. McMaster, L.P. Kahl, and F.Y. Liew. 1990. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 145:2281.
39. Yang, D. M., M. Rogers, and F. Y. Liew. 1991. Identification and character̂ ization of host-protective T cell epitopes of a major surface glycoprotein (gp63) from Leishmania major. Immunology 72:3-10.
40. Zhang, M., J. Gong, D. V. Iyer, B. E. Jones, R. L. Modlin, and P. F. Barnes. 1994. T cell cytokine responses in persons with tuberculosis and human immunodeficiency disease. J. Clin. Investig. 93:1733-1739.
41. Zhang, M., M. K. Gately, E. Wang, S. F. Wolf, S. Lu, R. L. Modlin, and P. F. Barnes. 1994. IL-12 at the site of disease in tuberculosis. J. Clin. Investig. 94:2435-2442.